233 related articles for article (PubMed ID: 37427561)
1. Gut microbiota regulates blood-cerebrospinal fluid barrier function and Aβ pathology.
Xie J; Bruggeman A; De Nolf C; Vandendriessche C; Van Imschoot G; Van Wonterghem E; Vereecke L; Vandenbroucke RE
EMBO J; 2023 Sep; 42(17):e111515. PubMed ID: 37427561
[TBL] [Abstract][Full Text] [Related]
2. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R
J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery.
Liu N; Yang C; Liang X; Cao K; Xie J; Luo Q; Luo H
J Nanobiotechnology; 2022 Oct; 20(1):439. PubMed ID: 36207740
[TBL] [Abstract][Full Text] [Related]
4. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
[TBL] [Abstract][Full Text] [Related]
5. Gut-derived β-amyloid: Likely a centerpiece of the gut-brain axis contributing to Alzheimer's pathogenesis.
Jin J; Xu Z; Zhang L; Zhang C; Zhao X; Mao Y; Zhang H; Liang X; Wu J; Yang Y; Zhang J
Gut Microbes; 2023; 15(1):2167172. PubMed ID: 36683147
[TBL] [Abstract][Full Text] [Related]
6. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment.
Nagpal R; Neth BJ; Wang S; Craft S; Yadav H
EBioMedicine; 2019 Sep; 47():529-542. PubMed ID: 31477562
[TBL] [Abstract][Full Text] [Related]
7. Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease.
Marizzoni M; Cattaneo A; Mirabelli P; Festari C; Lopizzo N; Nicolosi V; Mombelli E; Mazzelli M; Luongo D; Naviglio D; Coppola L; Salvatore M; Frisoni GB
J Alzheimers Dis; 2020; 78(2):683-697. PubMed ID: 33074224
[TBL] [Abstract][Full Text] [Related]
8. Scutellarin Modulates the Microbiota-Gut-Brain Axis and Improves Cognitive Impairment in APP/PS1 Mice.
Zhang S; Wei D; Lv S; Wang L; An H; Shao W; Wang Y; Huang Y; Peng D; Zhang Z
J Alzheimers Dis; 2022; 89(3):955-975. PubMed ID: 35964195
[TBL] [Abstract][Full Text] [Related]
9. The Gut Microbiota and Alzheimer's Disease.
Jiang C; Li G; Huang P; Liu Z; Zhao B
J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
[TBL] [Abstract][Full Text] [Related]
10. Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease.
Zhang L; Wang Y; Xiayu X; Shi C; Chen W; Song N; Fu X; Zhou R; Xu YF; Huang L; Zhu H; Han Y; Qin C
J Alzheimers Dis; 2017; 60(4):1241-1257. PubMed ID: 29036812
[TBL] [Abstract][Full Text] [Related]
11. Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App
Andersson E; Schultz N; Saito T; Saido TC; Blennow K; Gouras GK; Zetterberg H; Hansson O
Alzheimers Res Ther; 2023 Mar; 15(1):64. PubMed ID: 36964585
[TBL] [Abstract][Full Text] [Related]
12. Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer's disease.
Qian XH; Liu XL; Chen G; Chen SD; Tang HD
J Neuroinflammation; 2022 Sep; 19(1):236. PubMed ID: 36171620
[TBL] [Abstract][Full Text] [Related]
13. Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's Aβ amyloidosis.
Jiang R; Smailovic U; Haytural H; Tijms BM; Li H; Haret RM; Shevchenko G; Chen G; Abelein A; Gobom J; Frykman S; Sekiguchi M; Fujioka R; Watamura N; Sasaguri H; Nyström S; Hammarström P; Saido TC; Jelic V; Syvänen S; Zetterberg H; Winblad B; Bergquist J; Visser PJ; Nilsson P
Acta Neuropathol Commun; 2022 Jul; 10(1):96. PubMed ID: 35787306
[TBL] [Abstract][Full Text] [Related]
14. Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer's disease-type beta-amyloid neuropathological mechanisms.
Ho L; Ono K; Tsuji M; Mazzola P; Singh R; Pasinetti GM
Expert Rev Neurother; 2018 Jan; 18(1):83-90. PubMed ID: 29095058
[TBL] [Abstract][Full Text] [Related]
15. Microbiota Dysbiosis and Gut Barrier Dysfunction Associated with Non-Alcoholic Fatty Liver Disease Are Modulated by a Specific Metabolic Cofactors' Combination.
Quesada-Vázquez S; Bone C; Saha S; Triguero I; Colom-Pellicer M; Aragonès G; Hildebrand F; Del Bas JM; Caimari A; Beraza N; Escoté X
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430154
[TBL] [Abstract][Full Text] [Related]
16. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
Sun M; Ma K; Wen J; Wang G; Zhang C; Li Q; Bao X; Wang H
J Alzheimers Dis; 2020; 73(3):849-865. PubMed ID: 31884474
[TBL] [Abstract][Full Text] [Related]
17. Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis.
Daily JW; Kang S; Park S
Biofactors; 2021 Mar; 47(2):218-231. PubMed ID: 33347668
[TBL] [Abstract][Full Text] [Related]
18. Mannan oligosaccharide attenuates cognitive and behavioral disorders in the 5xFAD Alzheimer's disease mouse model via regulating the gut microbiota-brain axis.
Liu Q; Xi Y; Wang Q; Liu J; Li P; Meng X; Liu K; Chen W; Liu X; Liu Z
Brain Behav Immun; 2021 Jul; 95():330-343. PubMed ID: 33839232
[TBL] [Abstract][Full Text] [Related]
19. The gut microbiota is important for the maintenance of blood-cerebrospinal fluid barrier integrity.
Knox EG; Lynch CMK; Lee YS; O'Driscoll CM; Clarke G; Cryan JF; Aburto MR
Eur J Neurosci; 2023 Jan; 57(2):233-241. PubMed ID: 36453579
[TBL] [Abstract][Full Text] [Related]
20. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
